Project documents | Pembrolizumab with chemoradiation for untreated high-risk locally advanced cervical cancer [ID6138] | Guidance | NICE

Documents

Documents created during the development process.

Invitation to participate

Final scope (PDF 165 KB)

Published:

06 January 2025
Final stakeholder list (PDF 176 KB)

Published:

06 January 2025
NICE's response to comments on the draft scope and provisional stakeholder list (PDF 210 KB)

Published:

06 January 2025
Equality impact assessment (scoping) (PDF 129 KB)

Published:

06 January 2025

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators

Draft scope post referral (PDF 176 KB)

Published:

09 December 2024
Draft matrix of consultees and commentators post referral (PDF 177 KB)

Published:

09 December 2024

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: 6138

Draft scope post referral (PDF 181 KB)

Published:

22 November 2023
Draft matrix post referral (PDF 171 KB)

Published:

22 November 2023